drugset / Trial / NCT00483158

First Time in Man Study of Finafloxacin Hydrochloride

NCT00483158

Phase 1 Completed 95 enrolled MerLion Pharmaceuticals GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to study the safety of single doses and multiple doses of Finafloxacin hydrochloride in healthy volunteers. The level of Finafloxacin hydrochloride will be measured in the subjects blood and urine. One part of the study will assess if Finafloxacin hydrochloride eradicates Helicobacter pylori, a stomach bacteria. Another part of the study will assess the activity of the drug in urine.

Timeline

Start
2007-08
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Finafloxacin Small molecule Oral